Also, when FGFR1OP2 is fused to FGFR1, 8p11 myeloproliferative syndrome can result.
2.
FGFR1OP2, when fused with the fibroblast growth factor receptor 1 ( FGFR1 ), is shown to cause myeloproliferative syndrome.
3.
Patients with " preleukemic " conditions, such as myelodysplastic syndromes or myeloproliferative syndromes, who develop a chloroma are often treated as if they have transformed to acute leukemia.
4.
The French American British ( FAB ) classification is a bit more stringent, requiring a blast percentage of at least 30 % in bone marrow ( BM ) or peripheral blood ( PB ) for the diagnosis of AML . AML must be carefully differentiated from " preleukemic " conditions such as myeloproliferative syndromes, which are treated differently.
मोबाइल